Valeant

Valeant Shares Side on Report Ex CEO, Ex CFO Focus of DOJ Criminal Probe

Stocks FOXBusiness

Shares of Valeant Pharmaceuticals (VRX) tumbled as much as 6% in late trading on Monday after Bloomberg News reported the company's former CEO and CFO are the subjects of a criminal investigation by the Department of Justice for accounting fraud.

Continue Reading Below

This is a breaking-news story, please check back for updates.